71 related articles for article (PubMed ID: 21650226)
21. Molecular design, synthesis, and hypoglycemic and hypolipidemic activities of novel pyrimidine derivatives having thiazolidinedione.
Lee HW; Kim BY; Ahn JB; Kang SK; Lee JH; Shin JS; Ahn SK; Lee SJ; Yoon SS
Eur J Med Chem; 2005 Sep; 40(9):862-74. PubMed ID: 15908051
[TBL] [Abstract][Full Text] [Related]
22. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.
Wolf I; O'Kelly J; Rubinek T; Tong M; Nguyen A; Lin BT; Tai HH; Karlan BY; Koeffler HP
Cancer Res; 2006 Aug; 66(15):7818-23. PubMed ID: 16885386
[TBL] [Abstract][Full Text] [Related]
23. Histone deacetylase inhibitors and transforming growth factor-beta induce 15-hydroxyprostaglandin dehydrogenase expression in human lung adenocarcinoma cells.
Tong M; Ding Y; Tai HH
Biochem Pharmacol; 2006 Sep; 72(6):701-9. PubMed ID: 16844092
[TBL] [Abstract][Full Text] [Related]
24. Nonsteroidal anti-inflammatory drugs suppress glioma via 15-hydroxyprostaglandin dehydrogenase.
Wakimoto N; Wolf I; Yin D; O'Kelly J; Akagi T; Abramovitz L; Black KL; Tai HH; Koeffler HP
Cancer Res; 2008 Sep; 68(17):6978-86. PubMed ID: 18757412
[TBL] [Abstract][Full Text] [Related]
25. 15-hydroxyprostaglandin dehydrogenase is downregulated and exhibits tumor suppressor activity in gastric cancer.
Song HJ; Myung SJ; Kim IW; Jeong JY; Park YS; Lee SM; Nam WH; Ryu YM; Fink SP; Yang DH; Jung HY; Kim JH
Cancer Invest; 2011 May; 29(4):257-65. PubMed ID: 21469975
[TBL] [Abstract][Full Text] [Related]
26. New inhibitor(s) of 15-hydroxyprostaglandin dehydrogenase in human milk.
Nagai K; Tanaka T; Tsuruta K; Mori N
Am J Perinatol; 1988 Apr; 5(2):89-93. PubMed ID: 3348868
[TBL] [Abstract][Full Text] [Related]
27. Differential production of prostaglandin E(2) in male and female mice subjected to thermal injury contributes to the gender difference in immune function: possible role for 15-hydroxyprostaglandin dehydrogenase.
Gregory MS; Duffner LA; Hahn EL; Tai HH; Faunce DE; Kovacs EJ
Cell Immunol; 2000 Nov; 205(2):94-102. PubMed ID: 11104581
[TBL] [Abstract][Full Text] [Related]
28. Identification of dual cyclooxygenase-eicosanoid oxidoreductase inhibitors: NSAIDs that inhibit PG-LX reductase/LTB(4) dehydrogenase.
Clish CB; Sun YP; Serhan CN
Biochem Biophys Res Commun; 2001 Nov; 288(4):868-74. PubMed ID: 11688989
[TBL] [Abstract][Full Text] [Related]
29. Extremely low frequency electromagnetic fields modulate expression of inducible nitric oxide synthase, endothelial nitric oxide synthase and cyclooxygenase-2 in the human keratinocyte cell line HaCat: potential therapeutic effects in wound healing.
Patruno A; Amerio P; Pesce M; Vianale G; Di Luzio S; Tulli A; Franceschelli S; Grilli A; Muraro R; Reale M
Br J Dermatol; 2010 Feb; 162(2):258-66. PubMed ID: 19799606
[TBL] [Abstract][Full Text] [Related]
30. In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors.
Maccari R; Del Corso A; Giglio M; Moschini R; Mura U; Ottanà R
Bioorg Med Chem Lett; 2011 Jan; 21(1):200-3. PubMed ID: 21129963
[TBL] [Abstract][Full Text] [Related]
31. 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is up-regulated by flurbiprofen and other non-steroidal anti-inflammatory drugs in human colon cancer HT29 cells.
Chi X; Freeman BM; Tong M; Zhao Y; Tai HH
Arch Biochem Biophys; 2009 Jul; 487(2):139-45. PubMed ID: 19501039
[TBL] [Abstract][Full Text] [Related]
32. Nafazatrom (Bay g-6575), an antithrombotic and antimetastatic agent, inhibits 15-hydroxyprostaglandin dehydrogenase.
Wong PY; Chao PH; McGiff JC
J Pharmacol Exp Ther; 1982 Dec; 223(3):757-60. PubMed ID: 6754908
[TBL] [Abstract][Full Text] [Related]
33. [Effect of 15-hydroxy prostaglandin dehydrogenase inhibitor on the degradation of prostaglandins through guinea pig lung lobes and in tracheal strips (author's transl)].
Ishihara Y; Hayashi R; Hsu LH; Izumi T; Sugiyama Y; Kitamura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1980 Aug; 18(8):520-4. PubMed ID: 7420785
[No Abstract] [Full Text] [Related]
34. Intraluteal regulation of prostaglandin F2 alpha-induced prostaglandin biosynthesis in pseudopregnant rabbits.
Zerani M; Dall'Aglio C; Maranesi M; Gobbetti A; Brecchia G; Mercati F; Boiti C
Reproduction; 2007 May; 133(5):1005-16. PubMed ID: 17616729
[TBL] [Abstract][Full Text] [Related]
35. Inhibitors of 15-Prostaglandin Dehydrogenase To Potentiate Tissue Repair.
Antczak MI; Zhang Y; Wang C; Doran J; Naidoo J; Voruganti S; Williams NS; Markowitz SD; Ready JM
J Med Chem; 2017 May; 60(9):3979-4001. PubMed ID: 28398755
[TBL] [Abstract][Full Text] [Related]
36. Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor.
Muscará MN; McKnight W; Asfaha S; Wallace JL
Br J Pharmacol; 2000 Feb; 129(4):681-6. PubMed ID: 10683192
[TBL] [Abstract][Full Text] [Related]
37. Focusing downstream in lung cancer prevention: 15-hydroxyprostaglandin dehydrogenase.
Dubinett SM; Mao JT; Hazra S
Cancer Prev Res (Phila); 2008 Sep; 1(4):223-5. PubMed ID: 19138963
[No Abstract] [Full Text] [Related]
38. Effect of ethanol on 15-hydroxyprostaglandin dehydrogenase activity in the brain stem of the near-term fetal sheep.
Treissman D; Smith GN; Patrick J; Brien JF
Dev Pharmacol Ther; 1991; 16(1):48-52. PubMed ID: 1879252
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological activity of novel acridinylidene and benzylidene thiazolidinediones.
Mourão RH; Silva TG; Soares AL; Vieira ES; Santos JN; Lima MC; Lima VL; Galdino SL; Barbe J; Pitta IR
Eur J Med Chem; 2005 Nov; 40(11):1129-33. PubMed ID: 16040159
[TBL] [Abstract][Full Text] [Related]
40. Understanding human 15-hydroxyprostaglandin dehydrogenase binding with NAD+ and PGE2 by homology modeling, docking and molecular dynamics simulation.
Hamza A; Cho H; Tai HH; Zhan CG
Bioorg Med Chem; 2005 Jul; 13(14):4544-51. PubMed ID: 15908215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
